NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

TDD, you are absolutely correct. Over the years, experience with DCVax-L has been gathered treating hundreds of patients. This includes many patients who were not in the P3 trial.

It is absurd to believe that for both arms of the combo trial, a new modified autologous dendritic cell vaccine would be employed. To my knowledge, no data has ever been released as to the superior efficaciousness of this mysterious new or modified vaccine.

Utilization of DCVax-L in both arms of the trial is conclusive evidence that the UCLA combo trial investigators have plenty evidence that the vaccine (DCVax-L) has mucho efficacy. The shorts are therefore desperate to prove that the vaccine is not DCVax-L.